Blood and health traits study in older people on statins
Part of Heart & circulation clinical trials.
This study looks at blood markers (“biomarkers”) to better understand health risk in older adults who have multiple long-term illnesses and are taking statin medicines. It may help researchers predict outcomes and improve care for people with complex health needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 70 years old
- You have at least 2 ongoing chronic health conditions (not counting cholesterol treatment) lasting about 6 months or more
- You take a statin (cholesterol-lowering medicine) for at least 80% of the time during the year before the study start
- You do NOT have a prior history of major heart or blocked-artery problems like heart attack, unstable chest pain, stent/bypass surgery, or ischemic stroke/TIA
- You do NOT have certain large/serious aorta problems or a large aortic aneurysm
- You likely do NOT have familial hypercholesterolemia (an inherited form of very high cholesterol)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “subclinical atherosclerosis,” meaning early or silent plaque buildup in the arteries, in older people already taking statins. It may help doctors understand how well statins can slow artery damage in people with multiple health conditions.
This study looks at how blood vessel aging relates to the type of fatty buildup in your arteries that can cause heart attacks. If you've had a recent heart attack, chest pain (angina), or minor artery disease and do not have advanced heart failure, kidney failure, active cancer, or prior bypass surgery, you may be able to join.
This study looks at whether taking a low- to moderate-dose statin can prevent first-time heart and stroke problems in people age 70 and older. It may help you lower “bad cholesterol” (LDL) and see if that leads to fewer heart events over time.
This trial studies whether cholesterol-lowering medicine (a statin, specifically atorvastatin) improves health and benefits in people age 75 and older in everyday life. It may help doctors understand which older adults benefit most and how to use these medicines safely.
This trial compares two approaches to lower cholesterol in people aged 70+ with type 2 diabetes: a moderate statin dose versus adjusting treatment to reach a personalized LDL-C target. It aims to find which strategy better prevents heart problems.
This trial studies how to lower “bad” cholesterol (LDL) in people age 75 and older who have already had heart, brain, or leg/blood-vessel problems from blocked arteries. The goal is to see if the approach helps prevent further cardiovascular events (like heart attack or stroke).
Hear when a new Statin Treatment for Primary Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.